Yahoo · Oct 8, 2026
Is McKesson (MCK) Outperforming Other Medical Stocks This Year?
Here is how McKesson (MCK) and Avantor, Inc. (AVTR) have performed compared to their sector so far this year.

NYSE · AVTR
Healthcare · Medical - Instruments & Supplies
$15.55
Up+$0.15 (+0.96%)
Updated Oct 15, 2026, 12:11 AM
SID Score
6.1/10
Composite research score
Smart Money
62/100
Neutral
Price performance · AVTR
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 13, 2026
AVTR closed at $15.55 after 20 trading sessions, down 0.38% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 13, 2026 | $15.53 | $15.66 | $15.435 | $15.55 | 4.65M |
| Oct 12, 2026 | $15.71 | $15.755 | $15.39 | $15.49 | 5.92M |
| Oct 9, 2026 | $15.45 | $15.755 | $15.415 | $15.67 | 4.24M |
| Oct 8, 2026 | $15.22 | $15.42 | $14.96 | $15.39 | 12.13M |
| Oct 7, 2026 | $15.38 | $15.515 | $15.04 | $15.35 | 6.01M |
| Oct 6, 2026 | $15.95 | $16.375 | $15.42 | $15.43 | 11.39M |
| Oct 5, 2026 | $15.34 | $15.87 | $15.24 | $15.81 | 8.18M |
| Oct 2, 2026 | $15.11 | $15.375 | $14.965 | $15.34 | 6.15M |
| Oct 1, 2026 | $14.935 | $15.195 | $14.57 | $15.03 | 10.57M |
| Sep 30, 2026 | $15.16 | $15.36 | $15.05 | $15.05 | 7.38M |
| Sep 29, 2026 | $15.18 | $15.42 | $15.06 | $15.24 | 6.91M |
| Sep 28, 2026 | $15.10 | $15.41 | $15.07 | $15.29 | 9.44M |
| Sep 25, 2026 | $15.33 | $15.36 | $15.075 | $15.25 | 6.53M |
| Sep 24, 2026 | $14.72 | $15.43 | $14.67 | $15.38 | 7.72M |
| Sep 23, 2026 | $14.95 | $15.14 | $14.72 | $14.76 | 10.57M |
| Sep 22, 2026 | $15.13 | $15.3201 | $14.91 | $14.94 | 11.16M |
| Sep 21, 2026 | $15.39 | $15.59 | $15.04 | $15.10 | 9.19M |
| Sep 18, 2026 | $15.87 | $15.90 | $15.44 | $15.52 | 14.83M |
| Sep 17, 2026 | $15.81 | $16.05 | $15.635 | $15.86 | 9.83M |
| Sep 16, 2026 | $15.53 | $15.82 | $15.415 | $15.61 | 10.55M |
The latest Smart Investors Daily articles mentioning AVTR.
Company
Market Activity
Research & News
AVTR research
Company profile and research snapshot.
Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 13, 2026 | TD Cowen | Hold | — |
| Oct 13, 2026 | Morgan Stanley | Equal-Weight | — |
| Oct 7, 2026 | Barclays | Underweight | — |
| Sep 9, 2026 | UBS | Neutral | — |
| Jul 30, 2026 | Evercore ISI Group | In-Line | — |
No generated briefing is available yet.
Yahoo · Oct 8, 2026
Here is how McKesson (MCK) and Avantor, Inc. (AVTR) have performed compared to their sector so far this year.
Benzinga · Oct 7, 2026
Barclays analyst Luke Sergott maintains Avantor (NYSE:AVTR) with a Underweight and raises the price target from $13 to $15.
Yahoo · Oct 6, 2026
VTRS vs. AVTR: Which Stock Is the Better Value Option?
Yahoo · Oct 1, 2026
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Avantor (NYSE:AVTR) and the best and worst performers in the research tools & consumables industry.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning AVTR.